Intrinsiqq
Dermata Therapeutics Inc. logo

Dermata Therapeutics Inc. Insider Trading

DRMA

Compare
Last 12 months

Insiders bought 1K and sold $13 on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Kathleen D. Scott sold $13 on Jun 16, 92% of their stake, outside a plan.

Net open-market
+1K
1 buy · 1 sale
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
1 / 1
executives and directors
Last open-market buy
Feb 2026
Feb 17, 2026

Get an email when DRMA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 16No plan
    Kathleen D. Scott
    Director · sold 11 at $1.19
    $13
    92% of stake
  • Feb 17
    Munera Maria E Bedoya-Toro
    SVP, Regulatory Affairs · bought 1,000 at $1.27
    1K
    2174% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DRMA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with DRMA

CompareIntrinsic value
NXTCNextCure, Inc.
$6.45-4.87%40
GANXGain Therapeutics Inc.
$1.00-4.86%25
KURAKura Oncology Inc.
$6.91-5.99%10
IRDOpus Genetics Inc.
$3.99-2.21%10
PVCTProvectus Biopharmaceuticals, Inc.
$0.05+1.11%6
VSTMVerastem Inc.
$6.33-7.73%40
LXRXLexicon Pharmaceuticals, Inc.
$1.53-8.38%40
COLLCollegium Pharmaceutical Inc.
$24.72-1.94%85

Spot a number that looks wrong? Check it in DRMA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing DRMA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.